跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Onstal-Forte - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Onstal-Forte
Approved
STANDARD
Onstal-Forte
Stallion Laboratories Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
587f7b04ccc937a0
Company
Stallion Laboratories Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
587f7b04ccc937a0
Drug Approval Philippines Name
Onstal-Forte
Product Name
Onstal-Forte
Registration Number
DRP-6609-02
Brand Name
Onstal-Forte
Generic Name
Ondansetron (as hydrochloride dihydrate)
Dosage Form
Film-Coated Tablet
Dosage Strength
8 mg
Manufacturer
Stallion Laboratories Pvt. Ltd.
Trader
Endurance Healthcare Ltd.
Importer
Ambica International Corporation
Distributor
AGB Pharmaceutical Trading and Consultancy Corporation
Issuance Date
26 April 2025
Expiry Date
26 April 2037
Pharmacologic Category
Antiemetic (5-HT3-Receptor Antagonist)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
587f7b04ccc937a0
Type
Standard
Back to Philippines FDA Approvals